Merck & Co. (MRK) says Phase 3 TroFuse-015 trial of sac-TMT improved overall survival in advanced gastroesophageal adenocarcinoma but did not meet its progression-free survival endpoint
Newsquawk Staff ·
Merck & Co. (MRK) says Phase 3 TroFuse-015 trial of sac-TMT improved overall survival in advanced gastroesophageal adenocarcinoma but did not meet its progression-free survival endpoint.
What it means
A split readout of this kind, overall survival met with the progression-free endpoint missed, sits in a well-worn category in oncology. Regulators in this space have historically treated overall survival as the gold-standard endpoint, and approvals on the strength of OS alone, without a PFS benefit, are not without precedent; the cleaner the survival result, the weaker the PFS miss tends to matter for the filing path. The countervailing pattern is that mixed readouts have often been sold first and analysed later, particularly where the drug is one asset in a broad late-stage programme and the market's focus is on the higher-value indications rather than the indication in question. The competitive angle is the sharper one: this is a TROP2-targeted antibody-drug conjugate, a crowded class where relative efficacy across tumour types, and the margin of the OS benefit rather than its mere statistical significance, is what separates winners. What is worth watching next is the full data presentation, including hazard ratios and subgroup detail, whether management signals a filing intention on this dataset, and any read-across commentary for the other indications in the programme. A single readout of this kind rarely re-rates the name on its own; the follow-ons determine that.
- Intel's (INTC) EMIB-T have reportedly failed to meet Google's (GOOGL) expectations, which has led Google to ask TSMC (TSM) if it can switch back to CoWoS for its TPUs, Moneydj reports
- PRE-MARKET JAPANESE AND SOUTH KOREAN STOCKS NEWS: Japan Tobacco (2914 JT) cut its FY27 net profit forecast by JPY 1.38tln and is now projecting an annual net loss after losing control of its Russian operations
- Newsquawk Daily Asia-Pac Opening News - 20th November 2026
- FTSE Russell says Anthropic (ANT) will be a fast entry to the FTSE Global Equity Index Series
- US House committee report calls for sweeping restrictions on China's aerospace sector, potentially affecting Airbus (AIR FP) and French aerospace companies
Related headlines
- Assurant (AIZ) board approves 9% common stock dividend increase to USD 0.96 /shr from USD 0.88/shr14 hours ago
- Procter & Gamble (PG) to cut 20‑30% of its global manufacturing workforce by 203014 hours ago
- Ross Stores (ROST) Q3 2026 (USD) EPS 1.91 (exp. 1.86), Revenue 6.30bln (exp. 6.23bln)15 hours ago
- Intuit Inc. (INTU) Q1 FY27 (USD): Adj. EPS 2.91 (exp. 2.46), Revenue 4.4bln (exp. 4.3bln); Agrees to sell Mailchimp to Bending Spoons (BSP) for around USD 3.68bln, made up of USD 3.31bln in cash and USD 368mln in Bending Spoons stock15 hours ago
- Northrop Grumman (NOC) will not challenge Boeing’s (BA) USD 20bln F/A-XX Navy contract, Bloomberg reports15 hours ago
- Nvidia (NVDA) and Microsoft (MSFT) to roll out Vera Rubin NVL72 on Azure; Vera Rubin NVL72 systems are now operating in Azure data centres15 hours ago
- House Foreign Affairs Committee Chairman Mast moves to disclose Nvidia (NVDA) China export control licence information, revealing Nvidia and AMD (AMD) AI chip licences for China, according to a statement16 hours ago
- Meta (META) is counting on its USD 300 Muse Charm to lift its AI hardware business, The Information reports16 hours ago
- Apple's (AAPL) head of iPhone camera and photo software, John McCormack, retired at end of October, reports Bloomberg18 hours ago
- Anthropic (ANT) shares open at USD 111.50/shr (vs. IPO price of USD 83/shr)19 hours ago
- Newsquawk Daily European Equity Opening News - 20th November 20265 hours ago
- [MARKET ANALYSIS] Fixed firmer as energy falters and the risk tone remains negative2 hours ago
- [MARKET UPDATE]: T-note futures catch bid around settlement while ANT shares fall further; Dollar and stocks move lower16 hours ago
- European Movers: Ubisoft (UBI FP) -14%, ASML (ASML NA) -5%, Siemens Energy (ENR GY) -4%, SAP (SAP GY) -1.5%3 hours ago
- US Market Wrap: Risk sentiment swings to Anthropic IPO14 hours ago